                         SEQUENCE LISTING

<110>  THE GENERAL HOSPITAL CORPORATION
 
<120>  COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER

<130>  51536-002WO2

<140>  PCT/US2021/048753
<141>  2021-09-01

<150>  US 63/072,963
<151>  2020-09-01

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1
cgtcagtatc ttgggcaagt t                                                 21


<210>  2
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2
cgucaguauc uugggcaagu u                                                 21


<210>  3
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3
aacuugccca agauacugac g                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4
gctgcacttc agacgaatta t                                                 21


<210>  5
<211>  5
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5
rrach                                                                    5


